1Hafez MM, el-Wehedy GF, el-Kholy NM, et al. The value of HLA phenotypes in the prognosis of Hodgkin's lymphoma[ J]. Int J Cancer, 1985, 36(1) : 19 -22.
2Falk J, Osoba D. HL-A antigens and survival in Hodgkin's disease [J]. Lancet, 1971, 2:1118-1120.
3Niens M, Jarrett RF, Hepkema B, et al. HLA-A * 02 is associated with a reduced risk and HLA-A * 01 with an increased risk of develo- ping EBV + Hodgkin lymphoma[ J]. Blood, 2007, 110(9) : 3310 - 3315.
4Hjalgrim H, Rostgaard K, Johnson PC, et al. HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell re- sponse in EBV-related Hodgkin lymphoma [ J ]. Proc Natl Acad Sci USA, 2010, 107(14) : 6400 -6405.
5Huang X, van den Berg A, Gao Z, et al. Expression of HLA class 1 and HLA class II by tumor cells in Chinese classical Hodgkin lymphoma patients[J]. PLoS One, 2010, 5(5) : e10865,.
6Diepstra A, van Imhoff GW, Karim-Kos HE, et al. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognosticfactor in classical Hodgkin's lymphoma[ J ]. J Clin Oncol, 2007, 25 (21) : 3101 -3108.
7Diepstra A, Niens M, Vellenga E, et al. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class Ⅲ in Epstein- Barr-virus-negative Hodgkin' s lymphoma [ J ]. Lancet, 2005, 365 ( 9478 ) : 2216 - 2224.
8Straathof KC, Leen AM, Buza EL, et al. Characterization of Latent Membrane Protein 2 Specificity in CTL Lines from Patients with EBV- Positive Nasopharyngeal Carcinoma and Lymphoma [ J ]. J Immunol, 2005, 175 : 4137 -4147.
9Wang SS, Abdou AM, Morton LM et al. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology [ J ]. Blood, 2010, 115(23) : 4820 -4823.
10A1-Tonbary Y, Abdel-Razek N, Zaghloul H, et al. HLA class II pol- ymorphism in Egyptian children with lymphomas [ J ]. Hematology, 2004, 9(2) : 139 -145.
